Cardiac ischemia and impairment of vascular endothelium function in hearts from growth hormone-deficient rats: Protection by hexarelin

European Journal of Pharmacology

Volumn 334, Issue 2-3, 1997, Pages 201-207

  De Colonna, Vito Gennaro ^a   Rossoni, Giuseppe ^a   Bernareggi, Micaela ^a   Müller, Eugenio E ^a   Berti, Ferruccio ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

6 keto prostaglandin F(1 ); Angiotensin II; GH (growth hormone )deficiency; Heart; Hexarelin; Ischemia reperfusion; Rat

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; HEXARELIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; GROWTH HORMONE DEFICIENCY; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; VASCULAR ENDOTHELIUM;

6-KETOPROSTAGLANDIN F1 ALPHA; ANGIOTENSIN II; ANIMALS; ANTIBODIES; CORONARY CIRCULATION; ENDOTHELIUM, VASCULAR; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; GROWTH SUBSTANCES; IMMUNIZATION, PASSIVE; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OLIGOPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; VASOCONSTRICTOR AGENTS; VENTRICULAR PRESSURE;

EID: 0342894658     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01178-3     Document Type: Article

References (34)

1. Amato, G., Carella, C., Fazio, S., La Montagna, G., Cittadini, A., Sabatini, D., Marciano-Mone, C., Saccà, L., Bellastella, A., 1993. Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. J. Clin. Endocrinol. Metab. 77, 1671-1676.
2. Araki, H., Lefer, A.M., 1980. Role of prostacyclin in the preservation of ischemic myocardial tissue in the perfused cat heart. Circ. Res. 47, 757-763.
3. Arsenijevic, Y., Wehrenberg, W.B., Conz, A., Eshkol, A., Sizonenko, P.C., Aubert, M.L., 1989. Growth hormone deprivation induced by passive immunization against rat GH-releasing factor delays sexual maturation in the male rat. Endocrinology 124, 3050-3053.
4. Bercu, B.B., Yang, S.W., Masuda, R., Walker, R.F., 1982. Role of selected endogenous peptides in growth hormone-releasing hexapeptide activity: Analysis of growth hormone-releasing hormone, thyroid hormone-releasing hormone and gonadotropin-releasing hormone. Endocrinology 130, 2579-2586.
5. Berti, F., Rossoni, G., Niada, R., Folco, G.C., Omini, C., Tondo, C., 1986. Defibrotide, an antithrombotic substance that preserves postsynaptic α and β-adrenergic function in post acute infarcted rabbit hearts. J. Cardiovasc. Pharmacol. 8, 235-240.
6. Berti, F., Rossoni, G., Omini, C., Folco, G., Daffonchio, L., Viganò, T., Tondo, C., 1987. Defibrotide, an antithrombotic substance which prevents myocardial contracture in ischemic rabbit heart. Eur. J. Pharmacol. 135, 375-382.
7. Berti, F., Rossoni, G., Magni, G., Caruso, D., Omini, C., Puglisi, L., Galli, G., 1988. Nonsteroidal antiinflammatory drugs aggravate acute myocardial ischemia in the perfused rabbit heart: A role for prostacyclin. J. Cardiovasc. Pharmacol. 12, 438-444.
8. Berti, F., Rossoni, G., Della Bella, D., Villa, L.M., Buschi, A., Trento, F., Berti, M., Tondo, C., 1993. Nitric oxide and prostacyclin influence coronary vasomotor tone in perfused rabbit heart and modulate endothelin-1 activity. J. Cardiovasc. Pharmacol. 22, 321-326.
9. Bowers, C.Y., Sartor, A.O., Reynolds, G.A., Badger, T.M., 1991. On the actions of the growth hormone-releasing hexapeptide GHRP. Endocrinology 128, 2027-2035.
10. Buerke, M., Murohara, T., Skurk, C., Nuss, C., Tomaselli, K., Lefer, A.M., 1995. Cardioprotective effect of insulin-like growth factor 1 in myocardial ischemia followed by reperfusion. Proc. Natl. Acad. Sci. USA 92, 8031-8035.
11. Cella, S.G., De Gennaro Colonna, V., Locatelli, V., Bestetti, G.E., Rossi, G.L., Torsello, A., Wehrenberg, W.B., Müller, E.E., 1994a. Somatotropic dysfunction in growth hormone-releasing hormone-deprived neonatal rats: Effect of growth hormone replacement therapy. Pediatr. Res. 36, 315-322.
12. Cella, S.G., Locatelli, V., Broccia, M.L., Menegola, E., Giavini, E., De Gennaro Colonna, V., Torsello, A., Wehrenberg, W.B., Müller, E.E., 1994b. Long term changes of somatotropic function induced by deprivation of growth hormone-releasing hormone during the fetal life of the rat. J. Endocrinol. 140, 111-117.
13. Clark, R.G., Carlsson, L.M.S., Trojnar, J., Robinson, I.C.A.F., 1989. The effects of a growth hormone-releasing peptide and growth hormone-releasing factor in conscious and anaesthetized rats. J. Neuroendocrinol. 1, 249-255.
14. Daughaday, W.H., Mariz, I.K., Blethen, S.L., 1980. Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: A comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. J. Clin. Endocrinol. Metab. 51, 781-788.
15. De Gennaro Colonna, V., Rossoni, G., Bonacci, D., Ciceri, S., Cattaneo, L., Müller, E.E., Berti, F., 1996. Worsening of ischemic damage in hearts from rats with selective growth hormone deficiency. Eur. J. Pharmacol. 314, 333-338.
16. Deghenghi, R., Cananzi, M.M., Torsello, A., Battisti, C., Müller, E.E., Locatelli, V., 1994. GH-releasing activity of Hexarelin, a new growth hormone-releasing peptide, in infant and adult rats. Life Sci. 54, 1321-1328.
17. Dickson, S.L., Leng, G., Robinson, C.A.F., 1993. Systemic administration of growth hormone-releasing peptide activates hypothalamic arcuate neurons. Neuroscience 53, 303-306.
18. Donath, M.J., Jenni, R., Brunner, H.-P., Anrig, M., Kohli, S., Glatz, Y., Froesch, E.R., 1996. Cardiovascular and metabolic effects of insulin-like growth factor 1 at rest and during exercise in humans. J. Clin. Endocrinol. Metab. 81, 4089-4094.
19. Duerr, R.L., Huang, S., Miraliakbar, H.R., Clark, R., Chien, K.R., Ross, J., 1995. Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J. Clin. Invest. 95, 619-627.
20. Farber, N.E., Pieper, G.M., Thomas, J.P., Gross, G.J., 1988. Beneficial effects of iloprost in the stunned canine myocardium. Circ. Res. 62, 204-215.
21. Freestone, N.S., Ribaric, S., Mason, W.T., 1996. The effect of insulin-like growth factor-1 on adult rat cardiac contractility. Mol. Cell. Biochem. 163, 223-229.
22. Grilli, R., Bresciani, E., Torsello, A., Fornasari, D., Deghenghi, R., Müller, E.E., Locatelli, V., 1997. Tissue-specific expression of GHS-receptor mRNA in the CNS and peripheral organs of the male rat. 79th Annual Meeting of the Endocrine Society, abstract.
23. Hohlfeld, T., Strobach, H., Schrör, K., 1991. Stimulation of prostacyclin synthesis by defibrotide: Improved contractile recovery from myocardial 'stunning'. J. Cardiovasc. Pharmacol. 17, 108-115.
24. 2) stimulates growth hormone secretion by depolarisation in rat pituitary cell cultures. Proceeding of the 73rd Meeting of the Endocrine Society, p. 88.
25. Pradelles, P., Grassi, J., Maclouf, J., 1985. Enzyme immunoassays at eicosanoids using acetylcholine esterase as label: An alternative to radioimmunoassay. Anal. Chem. 57, 1170-1173.
26. Rosen, T., Bengtsson, B.A., 1990. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336, 285-288.
27. Saccà, L., Cittadini, A., Fazio, S., 1994. Growth hormone and the heart. Endocr. Rev. 15, 555-573.
28. Shakutsui, S., Abe, H., Chihara, K., 1989. GHRH treatment: Studies in an animal model. Acta Paediatr. Scand. Suppl. 349, 101-107.
29. Smith, R.G., Cheng, K., Schoen, W.R., Pong, S.S., Hickey, G., Jacks, T., Butler, B., Chan, W.W.-S., Chaung, L.-Y.P., Judith, F., Taylor, J., Wyvratt, M.J., Fisher, M.H., 1993. A nonpeptidyl growth hormone secretagogue. Science 260, 1640-1643.
30. Torsello, A., Luoni, M., Grilli, R., Guidi, M., Wehrenberg, W.B., Deghenghi, R., Müller, E.E., Locatelli, V., 1997. Hexarelin stimulation of growth hormone release and mRNA levels in an infant and adult rat model of impaired GHRH function. Neuroendocrinology 65, 31-37.
31. Wehrenberg, W.B., 1986. The role of growth hormone-releasing factor and somatostatin on somatic growth in rats. Endocrinology 118, 489-494.
32. Wehrenberg, W.B., Bloch, B., Phillips, B.J., 1984. Antibodies to growth hormone-releasing factor inhibit somatic growth. Endocrinology 115, 1218-1220.
33. Yang, B.C., Nichols, W.W., Mehta, J.L., 1993. Cardiac effects of acetyl-choline in rat hearts: Role of endothelium-derived relaxing factor and prostaglandins. Am. J. Physiol. 264, H1388-H1393.
34. Zapf, J., 1995. Physiological role of the insulin-like growth factor binding proteins. Eur. J. Endocrinol. 132, 645-650.